• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Retail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends

$500.00 – $7,990.00

Clear
SKU: KLI5479965 Category: Healthcare Market Research Pages: 245
  • Description
  • Table of Contents
  • Latest reports

Description

Retail Clinics 2015: Growth of Stores, Consumer Opinion, Leading Competitors, Sales of Products to Clinics (Diagnostic Tests, Pharmaceuticals, Vaccines), Clinic Sales Forecasts and Trends

Retail health clinics are a fast-growing and unique segment of the U.S. health care system. A concept less than two decades old, retail clinics are typically located in drug store, mass retailers or grocery stores for maximum convenience to the users. They offer low cost services, accept insuracne, staff with nurses or nurse practitioners and have increased hours generally over other medical venues. This report, Retail Clinics 2015, defines the industry and the opportunity for suppliers of healthcare clinics seeking new markets.

Key service providers are profiled. Among these are:

MinuteClinic
RediClinic
Reliance Medical Finance
Target Clinic Medical Associates
Walgreens
Access Health
Aurora Quick Care
Bellin Health FastCare
CareSpot
Clear Balance
The Little Clinic

Convenience clinics by nature are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. Retail Clinics 2015 looks at retail clinic concept’s impact and growth of market over the next five years, including:

The U.S. Market Size and Forecast for Retail Clinic Services, 2009-2019
Growth of U.S. Retail Clinic Locations
Market Share of Providers
Retail Clinic Service Revenues, 2009-2019
Sales to Retail Clinics by Suppliers, 2009-2019
Indicrect Revenues to Retailers from In-Store Clinic Customers, 2009-2019

While drug stores will continue to represent the majority of all retail clinics it is expected that other retailers will embrace the concept. The report breaks out current store locations by company owner and type.

The report uses both secondary and primary sources. In early Kalorama Information surveyed more than 2,000 U.S. consumers about their experiences with retail clinics. Retail Clinics 2015 contains the results of this research.

Information for this report was gathered from a wide variety of information including Kalorama’s survey and interviews with executives and experts. In addition sources includedcompany publications, catalogs, materials and public filings; government documents; trade journals, analysts’s reports and other sources.

Table of Contents

ONE: EXECUTIVE SUMMARY

Scope and Methodology

The U.S. Healthcare Market

The Emergence of Retail Clinics

TWO: INTRODUCTION

The U.S. Healthcare System Today

Overview

The Need for Alternatives

High Cost of Care

Inconsistent Quality of Care

Delays to Treatment

Healthcare Reform

Medical Tourism

The History of Retail Clinics

Retail Clinics Today

Business Model

Consumer Response

Growth Drivers

Challenges

Kalorama Survey on Consumer Retail Clinic Feedback

Establishing a Retail Clinic

Demographics and Location

Choice of Outlet

Systems and Scheduling

Funding and Expansion

Alliances

THREE: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2015

Types of Expenditures

Insurance Co-Payments

Direct Payments

Premiums and Plan Fees

Payment Methods

Cash or Check

Credit Cards

Loans and Lines of Credit

Flexible Spending Accounts

Health Savings Accounts

Medical Financing

Amount Financed

Elective Procedures

Non-Elective Procedures and Prescription Drugs

Non-Elective Procedures and Prescription Drugs

Consumers Who Pay Out-of-pocket

The Uninsured and Underinsured

Medicaid Recipients

Persons with Chronic Conditions

FOUR: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2014 – 2019

Trends

Out-of-pocket Expenditure Growth Drivers

Out-of-Pocket Expenditure Growth Constraints

Forecasts

Expenditures by Type

Payment Methods

Amount Financed

Types of Expenses Financed

Consumers Who Pay Out of Pocket

FIVE: RETAIL CLINIC SERVICE PROVIDERS

The Industry

Convenience Clinic Sales Forecasts

The Market

Competitive Positions of Key Players

SIX: RETAIL CLINIC SUPPLIERS

Point of Care Tests

The Industry

Competitive Positions of Key Players

Convenience Clinic Sales Forecasts

Clinical Chemistry and Immunoassays

The Industry

Competitive Positions of Key Players

Convenience Clinic Sales Forecasts

Vaccines

The Industry

Competitive Positions of Key Players

Convenience Clinic Sales Forecasts

SEVEN: OUTLETS FOR RETAIL CLINICS

Drug Stores

The Industry

Competitive Positions of Key Players

Other Medical Care

Food Stores

The Industry

Competitive Positions of Key Players

Other Medical Care

Convenience Clinic Sales Forecasts

Mass Merchandisers

The Industry

Competitive Positions of Key Players

Other Medical Care

Convenience Clinic Sales Forecasts

Other Outlets

The Industry

Competitive Positions of Key Players

Other Medical Care

Convenience Clinic Sales Forecasts

EIGHT: TOTAL MARKET

Retail Clinic Sales

Sales of Suppliers

Indirect Revenue

NINE: ISSUES AND TRENDS

Health Care Reform

Public Awareness

Competition with Primary Care Providers

Regulation

Overview

Regulation of Convenience Clinics

Pending Legislation

Development of Standards

Streamlining of Services

Physician Shortages

Labor Shortages

TEN: COMPANY PROFILES

Access Health

History and Lines of Business

Financial Information

Convenience Clinics

Aurora Quick Care

History and Lines of Business

Financial Information

Convenience Clinics

Bellin Health FastCare

History and Lines of Business

Financial Information

Convenience Clinics

Capital One Healthcare Finance

History and Lines of Business

Financial Information

Patient Financing

CareCredit

History and Lines of Business

Financial Information

Patient Financing

CareSpot

History and Lines of Business

Financial Information

Convenience Clinics

Clear Balance

History and Lines of Business

Financial Information

Patient Financing

Credit Medical

History and Lines of Business

Financial Information

Patient Financing

e-Financing Solutions

History and Lines of Business

Financial Information

Patient Financing

The Little Clinic

History and Lines of Business

Financial Information

Convenience Clinics

MedChoice Financial

History and Lines of Business

Financial Information

Patient Financing

MinuteClinic

History and Lines of Business

Financial Information

Convenience Clinics

RediClinic

History and Lines of Business

Financial Information

Convenience Clinics

Reliance Medical Finance

History and Lines of Business

Financial Information

Patient Financing

Target Clinic Medical Associates

History and Lines of Business

Financial Information

Convenience Clinics

Walgreens

History and Lines of Business

Financial Information

Convenience Clinics

APPENDIX: CONSUMER OPINION

U.S. Adults: Have You Visited a Retail Clinic?

LIST OF EXHIBITS

TWO: INTRODUCTION

Figure 2-1: Distribution of Health Plan Enrollment for Covered Workers by Plan Type, 1988 – 2014 (Conventional, HMO, PPO, POS, HDHP/SO)

Figure 2-2: National Health Expenditures (NHE) and NHE as a Percent of GDP, 1980 – 2015

Figure 2-3: Average Annual Health Insurance Premiums and Worker Contributions for Family Coverage, 2004 – 2014

Figure 2-4: Unnecessary Deaths Resulting from Variations in Health Care Quality, by Condition (Diabetes Care, Prenatal Care, Smoking Cessation, Beta Blocker Treatment, Breast Cancer Screening, Cholesterol Management, Colorectal Cancer Screening, Controlling High Blood Pressure)

Table 2-1: U.S. Health Care Coverage of the Non Elderly, 2013

Table 2-2: Cost Savings from Medical Tourism for Various Procedures, 2014

Table 2-3: Scope of Practice Laws for Non-Physician Medical Practitioners

Table 2-4: Estimated Number of U.S. Convenience Clinics, 2009 – 2019

Table 2-5: Characteristics of Retail Outlets, 2014

Table 2-6: Benefits and Drawbacks of Convenience Clinic Funding Approaches, 2015

THREE: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2015

Figure 3-1: Premium Increases vs. Increases in Workers Earnings and Prices, 2000 – 2014

Figure 3-2: Consumer Out-of-pocket Health Care Expenditures, 2014 (Co-pays, Direct Payments, Premiums)

Figure 3-3: Consumer Out-of-pocket Health Care Expenditures by Payment Type, 2014(HSAs, Health Care Financing Programs, Loans or Lines of Credit, FSAs, Credit Cards, Cash or Check)

Table 3-1: Main Business Activities of Selected Medical Financing Companies, 2014(Financing Elective Procedures, Financing Non-Elective Procedures, Non-Medical Consumer Credit)

Figure 3-4: Average Out-of-Pocket Payment by U.S. Residents with Health Care Spending by Percentile of Total Health Spending, 2014 (Cosmetic Surgery, Cosmetic Dentistry, Eye Procedures, Chiropractic Services, Hair Restoration, Fertility Treatments, Weight Loss Surgery, Other)

Figure 3-5: Methods of Financing Elective Procedures, 2014 (Loans or Lines of Credit, Cash or Check, Health Care Financing Programs, Credit Cards)

Figure 3-6: Average Share Paid Out-of-Pocket by U.S. Residents with Health Care Spending by Type of Service, 2014 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care)

Figure 3-7: Average Share Paid Out-of-pocket by U.S. Residents with Health Care

Spending by Percentile of Total Health Spending and Type of Service, 2014 (Hospital,

Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home

Health, Vision, Other Health Care)

Figure 3-8: Distribution of Out-of-pocket Spending on Non-Elective Procedures for the Average Person, 2014 (Prescription Drugs, Emergency Room, Dental, Vision, Other Health Care, Hospital, Outpatient, Office Based Visit)

Figure 3-9: Distribution of Out-of-pocket Spending for the Average Person, by Spending Level, 2014 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care)

Figure 3-10: Drug Cost Coverage by Payor Type (Public, Private, Cash): 1965, 1986, 2000, 2005, 2010, 2015

Table 3-2: Obesity in the United States, 1980 – 2019

Figure 3-11: Proportion of Adults under Age 65 with Chronic Conditions, 2014(Privately Insured, Medicare or Medicaid, Uninsured, Other)

FOUR: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2014 – 2019

Table 4-1: Selected Rx-to-OTC Switches in the United States, 1990 – 2014

Table 4-2: Consumer Out-of-pocket Expenditures per Worker, 2009–2019

Table 4-3: Consumer Out-of-pocket Expenditures by Type, 2009–2019

Figure 4-1: Proportion of Consumer Out-of-pocket Spending by Type of Health Care Expenditure, 2009, 2014, 2019 (Direct Payments, Co-pays, Premiums)

Table 4-4: Consumer Out-of-pocket Expenditures by Type, 2009–2019

Figure 4-2: Proportion of Consumer Out-of-pocket Spending by Payment Type, 2009, 2014, 2019 (Credit Cards, FSAs, Health Care Financing Programs, Cash or Check, Loans or Lines of Credit, HSAs)

Table 4-5: Amount of Consumer Out-of-pocket Expenditures for Elective Procedures That Are Financed, 2009–2019

Table 4-6: Amount of Consumer Out-of-pocket Expenditures for Non-Elective Procedures That Are Financed, 2009–2019

Figure 4-3: Proportion of Consumer Out-of-Pocket Spending for Elective Procedures That Is Financed (All Methods), 2014 – 2019 (Cosmetic Surgery, Cosmetic Dentistry, Eye Procedures, Chiropractic Services, Hair Restoration, Fertility Treatments, Weight Loss Surgery)

Figure 4-4: Distribution of Out-of-pocket Spending on Non-Elective Procedures for the Average Person, 2014, 2019 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Vision, Other Health Care)

Figure 4-5: Proportion of Consumer Out-of-pocket Spending for Non-Elective Procedures That is Financed (All Methods), 2014 – 2019 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision)

Table 4-7: Size of High Risk Groups for High Out-of-Pocket Health Care Expenditures, 2009–2019 (Uninsured and Underinsured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Chronic Conditions)

FIVE: RETAIL CLINIC SERVICE PROVIDERS

Table 5-1: The U.S. Market for Retail Clinic Services, 2009–2019 (Number of Clinics by Year End, Patients/Clinic/Day, Revenue per Patient, Total)

Figure 5-1: Growth of U.S. Retail Clinic Services, 2009–2019 (Number of Clinics, Revenues)

Table 5-2: Leading Service Providers’ Revenues and Market Share, U.S. Market for Convenience Clinics, 2014

Figure 5-2: Market Shares of Leading Retail Clinic Service Providers, 2014

SIX: RETAIL CLINIC SUPPLIERS

Table 6-1: Sales to Retail Clinics by Supplier Segment, 2009–2019 (POC Tests, Clinical Chemistry and Immunoassays, Vaccines, Total)

Figure 6-1: Growth of Retail Clinic Supplier Sales by Type of Supplier, 2009–2019(POC Tests, Other Tests, Vaccinations)

Table 6-2: U.S. Professional POC Test Sales, 2009–2019

Table 6-3: Leading POC Test Makers’ U.S. Revenues and Market Share, 2014

Table 6-4: U.S. Professional POC Test Sales to Retail Clinics, 2009–2019

Table 6-5: U.S. Professional POC Test Sales to Retail Clinics by Segment, 2009–2019(Cholesterol Tests, Diabetes Tests, Strep, Influenza & Pneumonia Tests, Other Tests,

Total POC Tests)

Table 6-6: U.S. Clinical Chemistry and Immunoassay Sales, 2009–2019

Table 6-7: Leading Clinical Chemistry and Immunoassay Suppliers’ Revenues andMarket Share, 2014

Table 6-8: U.S. Clinical Chemistry and Immunoassay Sales to Convenience Clinics,2009–2019

Table 6-9: U.S. Clinical Chemistry and Immunoassay Sales to Convenience Clinics, by Segment, 2009–2019 (Tests for Strep, Tests for TB, Other Tests, Total Tests)

Table 6-10: Diseases for Which Vaccines Are Available in the U.S., 2015

Table 6-11: U.S. Market for Preventative Vaccines, 2009–2019 (Adult Vaccines,Pediatric Vaccines, Total, Percent Change)

Table 6-12: Leading Vaccine Manufacturers’ U.S. Revenues and Market Share, 2014

Table 6-13: U.S. Vaccine Sales to Convenience Clinics, 2009–2019

Table 6-14: U.S. Vaccine Sales to Convenience Clinics, by Segment, 2009–2019 (Flu,HPV, MMR, Td/Tdap, Other Vaccines, Total)

SEVEN: OUTLETS FOR RETAIL CLINICS

Table 7-1: Number of Retail Clinics by Type of Retail Outlet, 2004–2019 (Drug Stores, Supermarkets, Mass Outlets, Other, Total)

Figure 7-1: Proportion of Retail Clinics by Type of Retail Outlet, 2009–2019 (Drug Stores, Food Stores, Mass Outlets, Other)

Table 7-2: Rents Collected From Retail Clinics by Type of Retail Outlet 2009–2019(Drug Stores, Supermarkets, Mass Outlets, Other, Total)

Figure 7-2: Proportion of Rents Collected From Retail Clinics by Type of Retail Outlet 2009–2019 (Drug Stores, Food Stores, Mass Outlets, Other)

Table 7-3: Indirect Income Generated by Retail Clinics by Type of Retail Outlet,2009–2019 (Drug Stores, Supermarkets, Mass Outlets, Other, Total)

Figure 7-3: Proportion of Indirect Income Generated by Retail Clinics by Type of Retail Outlet, 2009–2019 (Drug Stores, Food Stores, Mass Outlets, Other)

Table 7-4: Selected Retail Outlet Relationships with Convenience Clinics, 2015 (Type, Number of U.S. Locations, Clinic Partners)

Table 7-5: U.S. Drug Store Sales, 2009–2019

Table 7-6: Leading U.S. Drug Stores’ Revenues and Market Share, 2014

Table 7-7: U.S. Drug Store Direct Retail Clinic Revenues, 2009–2019(Number of Stores, Square Footage, Cost per Square Foot, Total Rents)

Table 7-8: U.S. Drug Store Indirect Retail Clinic Revenues, 2009–2019 (Number of Clinics, Patients/Clinic/Day, Incremental Sales per Patient, Total Indirect Revenue)

Figure 7-4: Direct vs. Indirect Revenues to Drug Stores from Retail Clinics, 2009–2019(Total Indirect Revenue, Total Results)

Table 7-9: U.S. Food Store Sales, 2009–2019

Table 7-10: Leading Food Stores Revenues and Market Share, 2014

Table 7-11: U.S. Food Stores Direct Retail Clinic Revenues, 2009–2019 (Number of Stores, Square Foot/Store, Cost/Square Foot, Total Rents)

Table 7-12: U.S. Food Store Indirect Retail Clinic Revenues, 2009–2019 (Number of Clinics,Patients/Clinic/Day, Incremental Sales per Patient, Total Indirect Revenue)

Figure 7-5: Direct vs. Indirect Revenues to Food Stores from Retail Clinics, 2009–2019(Total Indirect Revenue, Total Rents)

Table 7-13: U.S. Mass Merchandiser Retail Sales, 2009–2019

Table 7-14: Leading U.S. Mass Merchandisers Retail Revenues and Market Share,2014

Table 7-15: U.S. Mass Merchandiser Direct Retail Clinic Revenues, 2009–2019(Number of Stores, Square Foot/Store, Cost/Square Foot, Total Rents)

Table 7-16: U.S. Mass Merchandiser Indirect Retail Clinic Revenues, 2009–2019(Number of Clinics, Patients/Clinic/Day, Incremental Sales per Patient, Total

Indirect Revenue)

Figure 7-6: Direct vs. Indirect Revenues to Mass Merchandisers from Retail Clinics,2009–2019 (Total Indirect Revenue, Total Rents)

Table 7-17: U.S. Other Retail Sales, 2009–2019

Table 7-18: Leading Other Outlets Revenues and Market Share, 2014

Table 7-19: U.S. Other Outlets Direct Retail Clinic Revenues, 2009–2019(Number of Stores, Square Foot/Store, Cost/Square Foot, Total Rents)

Table 7-20: U.S. Other Outlets Indirect Retail Clinic Revenues, 2009–2019(Number of Clinics, Patients/Clinic/Day, Incremental Sales per Patient, Total Indirect Revenue)

Figure 7-7: Direct vs. Indirect Revenues to Other Outlets from Retail Clinics, 2009–2019(Total Indirect Revenue, Total Rents)

EIGHT: TOTAL MARKET

Table 8-1: Retail Clinic Service Revenues, 2009–2019

Table 8-2: Sales to Retail Clinics by Suppliers, 2009–2019

Table 8-3: Revenues to Retailers from In-Store Clinics, 2009–2019 (Indirect Revenues,

Direct Revenues, Total)

Figure 8-1: Revenues to Retailers from In-Store Clinics, 2009–2019(Indirect Income, Direct Income)

NINE: ISSUES AND TRENDS

Table 9-1: Selected U.S. Federal and State Health Care Oversight Bodies, 2015

Table 9-2: Retail Clinic Legislation by State, 2015

APPENDIX: CONSUMER OPINION

Table A-1: Survey Question Results of U.S. Adults Who Indicated Yes(I Have Visited a Retail Clinic)

 

    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
    November 29, 2023
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027
    October 18, 2023
    Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
    July 13, 2023

Related products

  • Placeholder image

    Organ Transplant Immunosuppressive Markets

    $995.00 – $1,990.00
  • Placeholder image

    RFID Opportunities in Healthcare in the U.S.

    $1,995.00 – $7,990.00
  • Placeholder image

    Hispanics and Healthcare: Understanding Demographics, Health Statistics, and Attitudes for More Effective Marketing

    $1,995.00 – $3,990.00
  • Placeholder image

    EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)

    $1,995.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Implantable Infusion Pumps: World Market Analysis, Forecasts to 2018Lab Automation Markets, Outlook 2014-2019, 4th Edition (Systems [Sample Transport,...
Scroll to top